Alternatively, AFP level of 400 ng/mL is included in two HCC staging systems, the Cancer of the Liver Italian Program (CLIP) and the Taipei Integrated Scoring (TIS) system, to predict long-term outcome of unselected HCC patients [10,11]. Here, AFP is linked to hepatocellular carcinoma.